Global Enteric Softgel Capsules Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global enteric softgel capsules market is primarily segmented by type into gelatin and non-gelatin softgel capsules. Gelatin capsules, derived from animal products, have traditionally dominated the market due to their widespread availability, affordability, and established consumer trust. However, with the growing demand for vegan and vegetarian products, non-gelatin softgel capsules, often made from plant-based materials like tapioca or cellulose, are gaining traction. This segment is expanding as more consumers seek alternatives that align with their dietary preferences or ethical considerations, reflecting a shift in consumer attitudes towards plant-based options.

Another important segmentation in the enteric softgel capsules market is based on sales channels, which include supermarkets and hypermarkets, pharmacies and drugstores, and online providers. Supermarkets and hypermarkets are significant in terms of volume sales, as they offer a wide range of over-the-counter health supplements and pharmaceuticals, often at competitive prices. Pharmacies and drugstores remain key players, particularly for prescription pharmaceuticals, where enteric softgel capsules are commonly used for their controlled release properties. However, the online sales channel is rapidly growing, driven by the increasing trend of e-commerce shopping and the convenience it offers consumers to purchase health-related products from home.

The application segment of the global enteric softgel capsules market is divided into health supplements and pharmaceuticals. Health supplements represent a large and expanding application area, as more individuals use softgel capsules to consume vitamins, minerals, and other dietary supplements. The enteric coating of these capsules helps protect sensitive ingredients from stomach acid and ensures that they are released in the intestines for better absorption. In the pharmaceutical sector, enteric softgel capsules are widely used for the delivery of specific medications, including pain relievers, anti-inflammatory drugs, and other therapeutics that require precise release control to improve efficacy and minimize side effects.

As the demand for enteric softgel capsules continues to rise across various sectors, market dynamics are shaped by evolving consumer preferences, regulatory advancements, and innovations in capsule production technologies. The gelatin and non-gelatin capsule segments are likely to witness sustained growth, while the increasing adoption of e-commerce platforms for purchasing health-related products will further propel the online sales channel. Additionally, with the growing focus on health and wellness, both the health supplements and pharmaceutical applications are expected to contribute significantly to the expansion of the market. The global enteric softgel capsules market is poised for substantial growth, driven by these diverse segments catering to the needs of health-conscious consumers.

Global Enteric Softgel Capsules Segment Analysis

In this report, the Global Enteric Softgel Capsules Market has been segmented by Type, Application, Sales Channel and Geography.

Global Enteric Softgel Capsules Market, Segmentation by Type

The Global Enteric Softgel Capsules Market has been segmented by Type into Gelatin Capsules, and Non-Gelatin Softgel Capsules.

The global enteric softgel capsules market is primarily segmented based on the type of material used for the capsule shell, with two key categories: gelatin capsules and non-gelatin softgel capsules. Gelatin capsules are widely used due to their versatility, cost-effectiveness, and ability to dissolve efficiently in the stomach, allowing for the effective release of the active ingredients. These capsules are made from animal-derived gelatin and are commonly used in the pharmaceutical, nutraceutical, and dietary supplement industries. Gelatin-based softgels have been a dominant choice for many years due to their established safety and efficacy profile.

On the other hand, non-gelatin softgel capsules are gaining traction as an alternative, particularly among consumers seeking vegetarian or halal-certified products. These capsules are typically made from plant-based ingredients such as hydroxypropyl methylcellulose (HPMC) or pullulan, which are suitable for individuals with dietary restrictions. Non-gelatin softgels are increasingly preferred for vegan and vegetarian formulations and have expanded the market's reach by catering to a broader, more health-conscious audience. As demand for plant-based products rises, the market for non-gelatin softgel capsules is expected to grow.

The segmentation by type plays a crucial role in shaping the market's dynamics, influencing manufacturing processes, raw material sourcing, and consumer preferences. While gelatin capsules dominate the market due to their long-standing presence and familiarity in the industry, non-gelatin options are quickly gaining popularity, driving innovation and product development. As consumer demand for more sustainable, plant-based alternatives grows, manufacturers may need to adapt their offerings to maintain competitiveness and meet the evolving market trends.

Global Enteric Softgel Capsules Market, Segmentation by Application

The Global Enteric Softgel Capsules Market has been segmented by Application into Health Supplements and Pharmaceuticals.

Enteric softgel capsules are increasingly utilized in the health supplements industry for the delivery of various vitamins, minerals, herbal extracts, and other nutritional ingredients. These supplements often contain sensitive compounds that may degrade in the acidic environment of the stomach, leading to reduced efficacy or gastrointestinal discomfort. Enteric coating in softgel capsules allows these supplements to bypass the stomach and release their contents in the intestine, where they can be absorbed more efficiently. Health-conscious consumers seeking to improve their overall well-being often prefer enteric softgel capsules for their enhanced bioavailability and reduced likelihood of gastric irritation.

Within the pharmaceutical sector, enteric softgel capsules serve as a vital drug delivery system for a wide range of medications targeting gastrointestinal disorders, cardiovascular diseases, neurological conditions, and other therapeutic areas. For pharmaceutical formulations requiring protection from stomach acid or specific site-specific release in the intestine, enteric softgel capsules offer a reliable solution. They enable precise dosing, improved drug absorption, and reduced side effects, enhancing patient compliance and therapeutic outcomes. Pharmaceutical companies leverage enteric softgel capsules for both generic and proprietary drugs, catering to the diverse needs of patients worldwide.

Segmenting the enteric softgel capsules market by application into health supplements and pharmaceuticals allows stakeholders to tailor their strategies and product offerings to the distinct requirements of each segment. For manufacturers, this segmentation enables targeted product development and marketing efforts, catering to the specific needs and preferences of health supplement consumers and pharmaceutical companies alike. Additionally, it facilitates market analysis and forecasting, providing valuable insights into the growth opportunities and demand drivers within each application segment.

Global Enteric Softgel Capsules Market, Segmentation by Sales Channel

The Global Enteric Softgel Capsules Market has been segmented by Sales Channel into Supermarket & Hypermarket, Pharmacy & Drugstore and Online Provider.

Supermarkets and hypermarkets represent traditional retail outlets where consumers can conveniently purchase enteric softgel capsules alongside other healthcare and wellness products. These large-scale retail establishments offer a wide variety of brands and formulations, catering to the diverse needs of consumers seeking dietary supplements and over-the-counter medications. Enteric softgel capsules stocked in these stores benefit from high visibility and accessibility, often prompting impulse purchases or recommendations from pharmacists or healthcare professionals available on-site.

Pharmacies and drugstores serve as trusted healthcare destinations where consumers can access professional advice and guidance regarding their medication needs. Enteric softgel capsules are prominently featured in these establishments, given their relevance to gastrointestinal health and drug delivery requirements. Pharmacists play a crucial role in recommending suitable enteric softgel capsule formulations based on individual patient needs, ensuring proper dosing and administration. The convenience and reliability of pharmacy and drugstore channels make them preferred destinations for consumers seeking pharmaceutical-grade enteric softgel capsules.

The online channel has emerged as a convenient and increasingly popular option for purchasing enteric softgel capsules, offering consumers the flexibility to browse, compare, and purchase products from the comfort of their homes. Online providers include e-commerce platforms, dedicated health and wellness websites, and direct-to-consumer brands, providing a vast array of enteric softgel capsule options at competitive prices. Consumers value the convenience of doorstep delivery, as well as the ability to access a broader range of products and read reviews from other users before making a purchase decision.

Global Enteric Softgel Capsules Market, Segmentation by Geography

In this report, the Global Enteric Softgel Capsules Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Enteric Softgel Capsules Market Share (%), by Geographical Region, 2024

North America represents one of the largest markets for enteric softgel capsules, driven by factors such as the high prevalence of gastrointestinal disorders, well-established healthcare infrastructure, and robust pharmaceutical industry. The region is characterized by a strong emphasis on innovation and product development, with pharmaceutical companies continuously investing in research and development to introduce advanced formulations and improve drug delivery systems. Additionally, the growing demand for dietary supplements and over-the-counter medications further fuels market growth in this region.

Europe is another significant market for enteric softgel capsules, supported by factors such as the increasing incidence of gastrointestinal diseases, aging population, and rising healthcare expenditure. Countries within the region prioritize healthcare access and quality, driving demand for pharmaceutical products and innovative drug delivery technologies. Regulatory frameworks promoting the safety and efficacy of healthcare products also contribute to market growth in Europe, fostering collaboration between pharmaceutical companies, research institutions, and regulatory authorities.

The Asia Pacific region is poised for rapid growth in the enteric softgel capsules market, fueled by factors such as the expanding pharmaceutical industry, rising disposable incomes, and improving healthcare infrastructure. Countries like India and China are major contributors to market growth, owing to their large population bases and increasing prevalence of chronic diseases. Additionally, the growing awareness about gastrointestinal health and the adoption of Western lifestyles contribute to the rising demand for enteric softgel capsules in the Asia Pacific region.

The Middle East and Africa exhibit growing demand for enteric softgel capsules, driven by factors such as improving access to healthcare, rising disposable incomes, and increasing investments in pharmaceutical manufacturing and distribution infrastructure. The region's high burden of gastrointestinal diseases, coupled with a growing focus on preventive healthcare, further boosts market growth for enteric softgel capsules in this region.

Latin America represents a promising market for enteric softgel capsules, propelled by factors such as the increasing prevalence of gastrointestinal disorders, expanding pharmaceutical industry, and growing consumer awareness about preventive healthcare. Countries within the region are witnessing rising healthcare expenditures and investments in healthcare infrastructure, creating opportunities for market expansion and product innovation in enteric softgel capsules.

This report provides an in depth analysis of various factors that impact the dynamics of Global Enteric Softgel Capsules Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Gastrointestinal Disorders
• Drug Absorption
• Reduced Gastric Irritation

• Enhanced Bioavailability - Enhanced bioavailability refers to the increased proportion of a drug that enters the systemic circulation after administration, leading to improved therapeutic outcomes. In the context of enteric softgel capsules, enhancing bioavailability is achieved through innovative formulation techniques and targeted drug delivery mechanisms. These capsules are designed to release their contents in the intestine rather than the stomach, bypassing degradation by gastric acids and enzymes and facilitating better absorption of the active pharmaceutical ingredient (API). By protecting the drug from premature degradation and ensuring its release at the desired site of action, enteric softgel capsules can significantly enhance bioavailability, resulting in more effective therapy with lower doses.

  One of the primary benefits of enhanced bioavailability is the potential for dose optimization and improved therapeutic efficacy. By increasing the proportion of the drug that reaches systemic circulation, enteric softgel capsules allow for lower doses to achieve the desired therapeutic effect, reducing the risk of adverse reactions and enhancing patient compliance. Moreover, enhanced bioavailability enables faster onset of action and prolonged duration of effect, contributing to better disease management and patient outcomes. This is particularly advantageous for medications with narrow therapeutic windows or those requiring precise dosing to achieve therapeutic benefits.

  Additionally, enhanced bioavailability can lead to cost savings for both patients and healthcare systems by reducing the overall quantity of drug required for effective therapy. With lower doses needed to achieve therapeutic effects, medication costs may be lowered, making treatment more accessible and affordable, especially for chronic conditions requiring long-term therapy. Furthermore, improved bioavailability can potentially extend the lifecycle of existing drugs by offering alternative formulations that enhance their efficacy and differentiate them in the market. Overall, the enhancement of bioavailability through enteric softgel capsules represents a promising avenue for optimizing drug delivery and improving patient outcomes across various therapeutic areas.

Restraints:

• Regulatory Hurdles
• High Manufacturing Costs
• Limited Product Differentiation

• Patent Expiry of Key Drugs - Patent expiry of key drugs refers to the termination of exclusive rights granted to a pharmaceutical company to produce and sell a particular medication. When a drug's patent expires, it opens the door for generic manufacturers to enter the market and produce equivalent versions of the medication. This event often leads to increased competition, resulting in lower prices for the drug and potential changes in market dynamics.

  For the enteric softgel capsules market, the patent expiry of key drugs presents both challenges and opportunities. On one hand, pharmaceutical companies that have relied on patented formulations of medications encapsulated in enteric softgel capsules may face increased competition from generic manufacturers offering cheaper alternatives. This can lead to a loss of market share and revenue for originator companies, especially if they are unable to differentiate their products or offer additional value beyond the generic alternatives.

  On the other hand, the patent expiry of key drugs can create opportunities for generic manufacturers and companies specializing in contract manufacturing of pharmaceuticals. These entities can leverage their expertise in formulation development and production to enter the market with generic versions of medications encapsulated in enteric softgel capsules. This increased competition may drive down prices, making enteric softgel capsules more affordable and accessible to patients. Additionally, it may spur innovation as companies strive to differentiate their products through novel formulations, improved drug delivery technologies, or value-added services.

  While the patent expiry of key drugs may pose challenges for originator companies in the enteric softgel capsules market, it also presents opportunities for increased competition, innovation, and broader access to essential medications for patients. Effective strategies for navigating this landscape may involve a combination of product differentiation, strategic partnerships, and investments in research and development to stay competitive in the evolving market.

Opportunities:

• Growing Aging Population
• Increasing Prevalence of Gastrointestinal Disorders
• Technological Advancements in Capsule Formulation

• Expansion in Emerging Markets - Expansion in emerging markets represents a significant opportunity for the enteric softgel capsules market, driven by several key factors. Emerging markets, including countries in Asia, Latin America, and Africa, are experiencing rapid economic growth, urbanization, and increasing healthcare expenditure. As a result, there is a growing demand for pharmaceutical products and improved healthcare services in these regions.

  One of the primary drivers of expansion in emerging markets is the rising prevalence of gastrointestinal disorders and chronic diseases. As lifestyles change and dietary habits evolve, the incidence of conditions such as acid reflux, peptic ulcers, and inflammatory bowel diseases is increasing in emerging markets. Enteric softgel capsules offer an effective solution for delivering medications to treat these conditions, as they protect the drug from gastric acid and ensure targeted release in the intestine, enhancing therapeutic efficacy.

  Pharmaceutical companies and contract manufacturers are increasingly focusing on expanding their presence in emerging markets to capitalize on the growing demand for healthcare products. These companies are investing in infrastructure, distribution networks, and marketing efforts to penetrate these markets and reach underserved populations. Additionally, regulatory reforms and initiatives aimed at improving access to essential medications are creating favorable conditions for market expansion in emerging economies.

Key players in Global Enteric Softgel Capsules Market include:

• Basf SE
• Catalent, Inc.
• Colorcon, Inc.
• Fuji Capsules Co., Ltd.
• Procaps
• Now Foods Inc.
• Thermo Fisher Scientific, Inc. (Patheon)
• Sirio Pharma Co., LTD
• Super Spectrim
• Osmotica Pharmaceuticals plc. (Trigen Laboratories)

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis